Moderna: Fair Value Cut Following Lower 2025 Sales ... - Morningstar

Moderna: Fair Value Cut Following Lower 2025 Sales ... - Morningstar

3 weeks from now

Jan 14, 2025  · On Jan.13, Moderna cut its 2025 sales guidance to $1.5 billion-$2.5 billion, down from prior guidance of $2.5 billion-$3.5 billion, partly due to waning covid vaccine demand and …

morningstar.com

Moderna's MRNA Technology Looks Undervalued Despite Lower …

3 weeks from now

Jan 14, 2025  · We've lowered our fair value estimate to $102 per share from $141 following the firm's Jan. 13 announcement of lower 2025 sales guidance for its covid and RSV vaccines as …

morningstar.com

MRNA Stock - Moderna Stock Price Quote - NASDAQ - Morningstar

3 weeks from now

2 days ago  · Moderna: Fair Value Cut Following Lower 2025 Sales Guidance and CMV Vaccine Uncertainty ... Moderna cut its 2025 sales guidance to $1.5 billion-$2.5 billion, down from prior …

morningstar.com

Moderna Stock Plunges Nearly 17% After Company Lowers 2025 …

3 weeks from now

Jan 13, 2025  · Moderna lowered its 2025 sales guidance by roughly $1 billion, as it continues to cut costs. The biotech company now expects 2025 revenue to come in between $1.5 billion …

nbclosangeles.com

JPM25: Moderna Slashes Guidance, Plots $1B In Cost Cuts This Year …

3 weeks from now

Jan 13, 2025  · The company has reduced its revenue guidance for 2025, as well, forecasting sales to land between $1.5 billion and $2.5 billion this year. ... Following news of Moderna’s …

fiercepharma.com

Moderna Slashes 2025 Sales Forecast, Shares Sink

3 weeks from now

Jan 13, 2025  · Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the drugmaker pre-announced fiscal 2024 sales below expectations. The company expects sales …

proactiveinvestors.com

Moderna Earnings: Maintaining Our $141 Fair Value ... - Morningstar

3 weeks from now

Nov 7, 2024  · We’re maintaining our $141 fair value estimate for Moderna following strong third-quarter sales and a brief return to profitability, ahead of an expected dip in sales in the fourth …

morningstar.com

What Led To Moderna’s 20% Stock Drop? Here’s The Full Story

3 weeks from now

Jan 13, 2025  · This adjustment comes as Moderna aims to cut costs while expanding its product portfolio. Moderna’s stock drops 20% after 2025 sales forecast cut The biotech firm now …

dataconomy.com

Michael Rednor - Carrier - LinkedIn

3 weeks from now

Morningstar’s analysts raised Netflix's fair value estimate to $550 from $500, noting the firm’s strong sales growth and margin expansion. ... while Thursday was the first trading day of 2025 ...

linkedin.com

Moderna's Vaccine Portfolio Is Advancing, Supporting Our $232 …

3 weeks from now

Mar 24, 2022  · Morningstar is an investment research company offering mutual fund, ETF, and stock analysis, ratings, and data, and portfolio tools. Discover actionable insights today.

morningstar.com

Revvity's 2025 Guidance Signals Cautious Optimism Amid

3 weeks from now

13 hours ago  · We are keeping our fair value estimate at $162 per share. After demand resets following the pandemic period, we expect mid-single-digit annualized revenue growth and …

morningstar.com

3 Stocks To Buy Before They Report Earnings - Morningstar

3 weeks from now

4 days ago  · Sekera: We maintained our $164 fair value per share following earnings. Now this is one where stock initially did take a little bit of a hit after earnings came out.

morningstar.com

VF Lacks A Competitive Edge, But Transformation Should

3 weeks from now

10 hours ago  · In fiscal 2024, the company’s wholesale sales fell 14%, but its direct-to-consumer sales fared little better, experiencing a 5% drop. As VF deals with its internal problems, its …

morningstar.com

Raising Makita's Fair Value To JPY 5,000 On Hopes Of ... - Morningstar

3 weeks from now

23 hours ago  · Our fair value estimate is JPY 5,000 per share, with an implied fiscal 2024 (ending March 2025) enterprise value/EBITDA of 9.1 times. We project revenue to grow 2.4% year on …

morningstar.com

Tesla's Should See Long-Term Profit Growth From AI

3 weeks from now

2 days ago  · We raise our Tesla fair value estimate to $250 from $210 following the company's fourth-quarter earnings. The increase is driven by our higher assumptions for Tesla's full self …

morningstar.com

Scotts Miracle-Gro Will Return To Growth Following ... - Morningstar

3 weeks from now

2 days ago  · We maintain our fair value estimate of $100 for Scotts Miracle-Gro following the company's fiscal first-quarter earnings. ... we forecast 2025 sales will be roughly 80% below …

morningstar.com